These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9144481)

  • 1. Wortmannin, a phosphatidylinositol 3-kinase inhibitor, blocks antigen-mediated, but not CD3 monoclonal antibody-induced, activation of murine CD4+ T cells.
    Shi J; Cinek T; Truitt KE; Imboden JB
    J Immunol; 1997 May; 158(10):4688-95. PubMed ID: 9144481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol 3-kinase activity is not essential for CD28 costimulatory activity in Jurkat T cells: studies with a selective inhibitor, wortmannin.
    Lu Y; Phillips CA; Trevillyan JM
    Eur J Immunol; 1995 Feb; 25(2):533-7. PubMed ID: 7875216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase.
    Truitt KE; Shi J; Gibson S; Segal LG; Mills GB; Imboden JB
    J Immunol; 1995 Nov; 155(10):4702-10. PubMed ID: 7594470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production.
    Ghiotto-Ragueneau M; Battifora M; Truneh A; Waterfield MD; Olive D
    Eur J Immunol; 1996 Jan; 26(1):34-41. PubMed ID: 8566081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differentiated state of intestinal lamina propria CD4+ T cells results in altered cytokine production, activation threshold, and costimulatory requirements.
    Hurst SD; Cooper CJ; Sitterding SM; Choi Jh; Jump RL; Levine AD; Barrett TA
    J Immunol; 1999 Dec; 163(11):5937-45. PubMed ID: 10570280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation.
    Lu Y; Rodriguez R; Bjorndahl J; Phillips CA; Trevillyan JM
    Eur J Immunol; 1996 Jun; 26(6):1278-84. PubMed ID: 8647205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual regulation between B7-1 (CD80) expressed on T cells and IL-4.
    Schweitzer AN; Sharpe AH
    J Immunol; 1999 Nov; 163(9):4819-25. PubMed ID: 10528182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD28/B7 pathway costimulates the response of primary murine T cells to superantigens as well as to conventional antigens.
    Blankson JN; Morse SS
    Cell Immunol; 1994 Aug; 157(1):306-12. PubMed ID: 7518754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3 kinase activity is not essential for B7-1-mediated costimulation of proliferation or development of cytotoxicity in murine T cells.
    Ni HT; Deeths MJ; Mescher MF
    J Immunol; 1996 Sep; 157(6):2243-6. PubMed ID: 8805620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin.
    Ward SG; Wilson A; Turner L; Westwick J; Sansom DM
    Eur J Immunol; 1995 Feb; 25(2):526-32. PubMed ID: 7875215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.
    Johnson-Léger C; Christenson JR; Holman M; Klaus GG
    J Immunol; 1998 Nov; 161(9):4618-26. PubMed ID: 9794390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.
    Gramaglia I; Weinberg AD; Lemon M; Croft M
    J Immunol; 1998 Dec; 161(12):6510-7. PubMed ID: 9862675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation.
    Galvin F; Freeman GJ; Razi-Wolf Z; Hall W; Benacerraf B; Nadler L; Reiser H
    J Immunol; 1992 Dec; 149(12):3802-8. PubMed ID: 1281187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
    Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4-mediated signals induce T cell dysfunction in vivo.
    Chirmule N; Avots A; LakshmiTamma SM; Pahwa S; Serfling E
    J Immunol; 1999 Jul; 163(2):644-9. PubMed ID: 10395653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
    Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
    J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.